Login / Signup

Empagliflozin Protects Cardiac Mitochondrial Fatty Acid Metabolism in a Mouse Model of Diet-Induced Lipid Overload.

Marina Makrecka-KukaStanislava KorzhMelita VidejaKarlis VilksHelena CiruleJanis KukaMaija DambrovaEdgars Liepinsh
Published in: Cardiovascular drugs and therapy (2021)
Empagliflozin treatment preserves mitochondrial fatty acid oxidation in the heart under conditions of chronic lipid overload.
Keyphrases
  • fatty acid
  • mouse model
  • oxidative stress
  • heart failure
  • left ventricular
  • hydrogen peroxide
  • electron transfer